There is 1 paper on aging in Pimephales promelas: none in people yet, 1 in cells.
See all 1 papers on Pimephales promelas
- Cells1
Interventions
1Decitabine
upcellular senescence1downMYC1upsenescence-associated secretory phenotype (SASP)1downtelomerase activity1
1 study
Decitabine
upcellular senescence1downMYC1upsenescence-associated secretory phenotype (SASP)1downtelomerase activity1
Decitabine decreases MYC in P. promelas cells (DNA demethylation in EPC cells).
“DNA demethylation suppressed the transcription of myc and its downstream target, telomerase reverse transcriptase (tert)”
CellsDNA demethylation in EPC cells
Gene
Decitabine decreases telomerase activity in P. promelas cells (DNA demethylation in EPC cells) (no more than modest decrease).
“telomerase activity was no more than modestly decreased”
CellsDNA demethylation in EPC cells
Gene
Decitabine induces senescence-associated secretory phenotype (SASP) in 5-Aza-dC treated cells.
“RT-qPCR analyses revealed significant up-regulation of senescence markers such as p53-p21 and p16-Rb pathways as well as several SASP factors in 5-Aza-dC treated cells.”
Cellsin 5-Aza-dC treated cells
Gene
Decitabine induces cellular senescence in EPC cells.
“DNA demethylation by 10 μM of 5-Aza-dC caused cell growth arrest, morphological senescence-like phenotypes and induction of senescence-associated β-galactosidase (SA-β-gal) activity”
Cellsin EPC cells10 μM
Gene